Hot on the trail in the TME: Clues from a trilogy of checkpoint inhibitor trials in nasopharyngeal cancer
Cancer Cell · 2023
DOI: 10.1016/j.ccell.2023.04.013 ↗Kurz gefasst
Kommentar in der Zeitschrift Cancer Cell, 2023. Verfasst von Brigette B Y Ma und 1 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chines…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: NIDCR, Bristol-Myers Squibb, Merck Sharp and Dohme.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Department of Radiation Oncology, Stanford University, Stanford, CA, USA. Electronic address: qle@stanford.edu.
Förderung
- NIDCR
- Bristol-Myers Squibb
- Merck Sharp and Dohme
- Chinese University of Hong Kong
- NCI
Zitieren
APA
Ma, B. B. Y., & Thu Le, Q. (2023). Hot on the trail in the TME: Clues from a trilogy of checkpoint inhibitor trials in nasopharyngeal cancer. Cancer Cell. https://doi.org/10.1016/j.ccell.2023.04.013
Vancouver
Ma BBY, Thu Le Q. Hot on the trail in the TME: Clues from a trilogy of checkpoint inhibitor trials in nasopharyngeal cancer. Cancer Cell. 2023. doi:10.1016/j.ccell.2023.04.013
BibTeX
@article{Ma2023,
author = {Ma, Brigette B Y and Thu Le, Quynh},
title = {Hot on the trail in the TME: Clues from a trilogy of checkpoint inhibitor trials in nasopharyngeal cancer},
journal = {Cancer Cell},
year = {2023},
doi = {10.1016/j.ccell.2023.04.013}
}
EUVIMED